אסיף מאגר המחקר החקלאי

Inhibition of pancreatic stellate cell activation by halofuginone prevents pancreatic xenograft tumor development

Year:

2010

Source of publication :

Authors :

Volume :

39

Co-Authors:

Spector, I., Institute of Animal Sciences, ARO, Volcani Center, Bet Dagan 50250, Israel, Department of Animal Science, Faculty of Agriculture, Hebrew University of Jerusalem, Israel
Honig, H., Institute of Animal Sciences, ARO, Volcani Center, Bet Dagan 50250, Israel
Kawada, N., Department of Hepatology, Graduate School of Medicine, Osaka City University, Japan
Nagler, A., Department of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel
Genin, O., Institute of Animal Sciences, ARO, Volcani Center, Bet Dagan 50250, Israel
Pines, M., Institute of Animal Sciences, ARO, Volcani Center, Bet Dagan 50250, Israel

Facilitators :

Link :

Abstract:

Objectives: Most solid tumors consist of neoplastic and nonneoplastic cells and extracellular matrix components. In the pancreas, activated stellate cells (PSCs) are the source of the extracellular matrix proteins. We evaluated the significance of PSC activation in tumor establishment and development in mouse xenografts. Methods: Xenografts were established by implanting human pancreatic cancer cells (MiaPaca-2) subcutaneously or orthotopically by injecting them into the spleen. Fibrosis was induced by cerulein. Collagen level was evaluated by Sirius red staining. Prolyl 4-hydroxylase β and stellate cell activation-associated protein (Cygb/STAP) were determined by immunohistochemistry. Results: Halofuginone inhibited subcutaneous tumor development implanted with Matrigel and reduced collagen and prolyl 4-hydroxylase β levels. Few tumors, which developed slowly, were observed after MiaPaca-2 implantation without Matrigel. Increase in tumor number and rate of development were observed with addition of PSCs from control pancreas, and further increase was observed when the PSCs were from cerulein-treated mice. Preincubation of the PSCs with halofuginone elicited Cygb/STAP level reduction and tumor growth inhibition. More tumors developed orthotopically in cerulein-treated mice than in controls; this was prevented by halofuginone. Conclusions: Extracellular matrix production by activated PSCs is essential for tumor establishment and growth. Thus, inhibition of PSC activation is a viable means of reducing pancreatic tumor development. Copyright © 2010 by Lippincott Williams & Wilkins.

Note:

Related Files :

Related Content

More details

You may also be interested in